ATRYN AGREEMENTAtryn Agreement • April 11th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 11th, 2014 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is effective as of March 31, 2014 (the “Effective Date”), by and between rEVO Biologics, Inc., a Massachusetts corporation, having its principal place of business located at 175 Crossing Boulevard, Framingham, Massachusetts, 01702 (“rEVO”) and Laboratoire français du Fractionnement et des Biotechnologies, a French Corporation, having its principal place of business located at 3 avenue des Tropiques - ZA de Courtaboeuf, 91940 (“LFB” and together with rEVO, the “Parties” and each a “Party”).